Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives USFDA Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 % (OTC)